Short name: AMI-25, generic name: Ferumoxide (SPIO)
Ferumoxides are superparamagnetic (T2*) MRI contrast agents, so the largest signal change is on T2 and T2* weighted images.
The agent distributes relatively rapidly to organs with reticuloendothelial cells primarily the liver, spleen and bone marrow. The liver shows decreased signal intensity, as does the spleen and marrow. The agent is taken up by the normal liver, resulting in increased CNR between tumor and normal liver. Hepatocellular lesions, such as adenoma or focal nodular hyperplasia, contain reticuloendothelial cells, so they will behave similar to the liver, with decreased signal on T2 weighted images. On T1 images, there is typically some circulating contrast agent, and blood vessels show increased signal intensity.
Current MRI protocols involve T1 weighted breath-hold gradient echo images of the liver, and fast spin echo T2 weighted pictures. This requires about 15 minutes. The patient is then removed from the scanner, and the contrast agent administered. After contrast administration, the same pulse sequences are again repeated.

Quick Overview
Please note that there are different common names for this artifact.

Flow effects in MRI produce a range of artifacts, e.g. intravascular signal void by time of flight effects; turbulent dephasing and first echo dephasing, caused by flowing blood.
Through movement of the hydrogen nuclei (e.g. blood flow), there is a location change between the time these nuclei experience a radio frequency pulse and the time the emitted signal is received (because the repetition time is asynchronous with the pulsatile flow).
The blood flow occasionally produces intravascular high signal intensities due to flow related enhancement, even echo rephasing and diastolic pseudogating. The pulsatile laminar flow within vessels often produces a complex multilayered band that usually propagates outside the head in the phase encoded direction. Blood flow artifacts should be considered as a special subgroup of motion artifacts.

Artifacts can be reduced by reduction of phase shifts with flow compensation (gradient moment nulling), suppression of the blood signal with saturation pulses parallel to the slices, synchronization of the imaging sequence with the heart cycle (cardiac triggering) or can be flipped 90° by swapping the phase//frequency encoding directions.

See also Flow Related Enhancement and Flow Effects.

A problem occurs in the phase encoding direction, where the phases of signal-bearing tissues outside of the FOV in the y-direction are a replication of the phases that are encoded within the FOV. This signal will be mapped (wrapped, backfolded) back into the image at incorrect locations.
Foldover suppression (phase oversampling, no phase wrap) is a user-selectable parameter that maps this signal to its correct location outside the FOV, then discards any signal from outside the FOV before displaying the image. In order to be able to choose this parameter, in most cases more than an average is necessary.

See also Phase Wrapping Artifact and Oversampling.

The MRI equipment consists of following components:
Better MRI equipment and software design along with the latest information technology improves system maintenance and overall communication. Software and digital imaging and communications in medicine (DICOM) compatibility allows to network into hospital databases, helps to modify pulse sequences, data post processing, and archiving via picture archiving and communication system (PACS).

See also the related poll result: 'Most outages of your scanning system are caused by failure of'

(MRA) Magnetic resonance angiography is a medical imaging technique to visualize blood filled structures, including arteries, veins and the heart chambers. This MRI technique creates soft tissue contrast between blood vessels and surrounding tissues primarily created by flow, rather than displaying the vessel lumen. There are bright blood and black blood MRA techniques, named according to the appearance of the blood vessels. With this different MRA techniques both, the blood flow and the condition of the blood vessel walls can be seen. Flow effects in MRI can produce a range of artifacts. MRA takes advantage of these artifacts to create predictable image contrast due to the nature of flow.
Technical parameters of the MRA sequence greatly affect the sensitivity of the images to flow with different velocities or directions, turbulent flow and vessel size.
This are the three main types of MRA:
All angiographic techniques differentially enhance vascular MR signal. The names of the bright blood techniques TOF and PCA reflect the physical properties of flowing blood that were exploited to make the vessels appear bright. Contrast enhanced magnetic resonance angiography creates the angiographic effect by using an intravenously administered MR contrast agent to selectively shorten the T1 of blood and thereby cause the vessels to appear bright on T1 weighted images.
MRA images optimally display areas of constant blood flow-velocity, but there are many situations where the flow within a voxel has non-uniform speed or direction. In a diseased vessel these patterns are even more complex. Similar loss of streamline flow occurs at all vessel junctions and stenoses, and in regions of mural thrombosis. It results in a loss of signal, due to the loss of phase coherence between spins in the voxel.
This signal loss, usually only noticeable distal to a stenosis, used to be an obvious characteristic of MRA images. It is minimized by using small voxels and the shortest possible TE. Signal loss from disorganized flow is most noticeable in TOF imaging but also affects the PCA images.
Indications to perform a magnetic resonance angiography (MRA):
Conventional angiography or computerized tomography angiography (CT angiography) may be needed after MRA if a problem (such as an aneurysm) is present or if surgery is being considered.

See also Magnetic Resonance Imaging MRI.